Adrian Liam Gill

Adrian Liam Gill

AstraZeneca, Sweden - Södertälje / Sweden
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4400507
-
person_outline Adrian Liam Gill's MOST POPULAR ARTICLES
1-) Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activityS Howard, V Berdini, JA Boulstridge, MG Carr, DM Cross, J Curry, ...Journal of medicinal chemistry 52 (2), 379-388, 20093542009
2-) RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1-and RAS-driven cancersRJ Nichols, F Haderk, C Stahlhut, CJ Schulze, G Hemmati, D Wildes, ...Nature cell biology 20 (9), 1064-1073, 20182242018
3-) Identification of novel p38α MAP kinase inhibitors using fragment-based lead generationAL Gill, M Frederickson, A Cleasby, SJ Woodhead, MG Carr, ...Journal of medicinal chemistry 48 (2), 414-426, 20052142005
4-) 3, 4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitorsAL Gill, MG Carr, MA O\'brien, PG Wyatt, V Berdini912006
5-) Automated iterative Csp3–C bond formationDJ Blair, S Chitti, M Trobe, DM Kostyra, HMS Haley, RL Hansen, ...Nature 604 (7904), 92-97, 2022902022